Write in a clean editor, then format for Clinical and Applied Thrombosis/Hemostasis in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical and Applied Thrombosis/Hemostasis is a peer-reviewed journal published by SAGE, covering Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical and Applied Thrombosis/Hemostasis, 12(3), pp. 45–58.
Formats any DOI in Clinical and Applied Thrombosis/Hemostasis style. No sign-up. |
| Publishes research in | Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Atrial Fibrillation Management and Outcomes Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis |
| ISSN | 1076-0296 |
| Citation impact (2-yr) | 1.59 |
| h-index | 76 |
| i10-index | 1,559 |
| Total citations | 52,629 |
| Article processing charge | $2,200 |
| Open access | Yes |
| Top institutions publishing here | Loyola University Medical Center |
| Journal website | cat.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death in a proportion of patients. Among other factors and direct viral effects, the increase in the vasoconstrictor angiotensin II, the…
Inflammation plays an important role in the pathophysiology of vascular disease. In this review, we consider the associations between the neutrophil-lymphocyte ratio (NLR; an indicator of inflammation) and vascular disease and its associated risk factors. The NLR has received attention due to its role as an independent prognostic factor for coronary artery disease. The NLR…
This study evaluated enoxaparin alone versus initial enoxaparin followed by warfarin in secondary prevention of venous thromboembolic events in adults with active malignancy. Cancer patients (n = 122) with acute symptomatic venous thromboembolic events were randomly allocated to receive subcutaneous enoxaparin 1.0 mg/kg every 12 hours for 5 days, followed by 1.0 mg/kg daily (group…
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical…
Dabigatran etexilate is a novel, oral reversible direct thrombin inhibitor that is rapidly absorbed and converted to its active form, dabigatran. Dabigatran has been shown to be a potent, competitive, and reversible inhibitor of thrombin, inhibiting both thrombin activity and generation. Studies in healthy volunteers and in patients undergoing orthopedic surgery indicate that dabigatran has…
Human Factors: The Journal of the Human Factors and Ergonomics Society
Human Relations
International Journal of Advanced Robotic Systems
International Journal of Stroke
Journal of Applied Gerontology
Journal of Cerebral Blood Flow & Metabolism
Journal of Composite Materials
Journal of Conflict Resolution
